Human chorionic gonadotropin in colorectal cancer and its relationship to prognosis

34Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

The presence of human chorionic gonadotropin in large bowel cancers was studied immunohistochemically using an immunoperoxidase technique. HCG-positive tumour cells were present in 42 of 194 adenocarcinomas examined (22.0% of colon cancer and 21.2% of rectal cancers). On histological grading, the hCG-positive rate tended to rise as the degree of differentiation decreased. HCG was detected more frequently in cancers invading the total bowel wall (27%) than in those invading the partial wall (17.1%). Lymph node, liver or peritoneal metastases were present more frequently in hCG-positive tumours than in hCG-negative tumours. Furthermore, there was an intimate correlation between the presence of hCG-positive tumour cells and CEA doubling times in nine cases with untreated liver metastasis. The survival rate for patients with tissue hCG-positive cells was lower than for those with hCG-negative tumours. Thus, the presence of tissue hCG in colorectal cancers may be a biological marker of prognostic significance. © The Macmillan Press Ltd., 1989.

Cite

CITATION STYLE

APA

Yamaguchi, A., Ishida, T., Nishimura, G., Kumaki, T., Katoh, M., Kosaka, T., … Miyazaki, I. (1989). Human chorionic gonadotropin in colorectal cancer and its relationship to prognosis. British Journal of Cancer, 60(3), 382–384. https://doi.org/10.1038/bjc.1989.289

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free